Adverse clinical outcomes associated with a low dose and a high dose of aspirin following percutaneous coronary intervention: a systematic review and meta-analysis

Table 4 Other antiplatelet/anticoagulants used by the patients included in this analysis

Other antiplatelets/anticoagulants	GHOST	CURRENT OASIS 7	CURE	HORIZONS-AMI
Heparin	+++	−	−	−
GP IIb/IIIa inhibitors	+	+	+++	−
Oral anticoagulants (warfarin/Coumadin)	+	−	+	+
Clopidogrel	++++	++++	++++	++++

Abbreviations: GP glycoproteins, “+”: less than 25 % of patients, “++”: 26 to 50 % of patients, “+++”: 51 to 75 % of patients, “++++”: 76 to 100 % of patients

ISSN: 1471-2261